Solid phase synthesis of arylretinamides
A solid phase synthetic method for preparing arylretinamides is provided. The method comprises reacting hexachloroacetone with a solvent-suspended resin-bound triphenylphosphine to provide a suspension comprising an activated chlorinating reagent; reacting retinoic acid with the activated chlorinating reagent to provide retinoyl chloride; adding pyridine and a select arylamine to the resulting mixture; and stirring the resulting mixture for a time and at a temperature sufficient for the select arylamine to react with the retinoyl chloride and provide the arylretinamide. Also provided, are select arylretinamides that can be prepared by the present method, and methods of using such arylretinamides to induce apoptosis in cancer cells.
1. A compound according to the structure
wherein R 4 or R 5 is NO 2 and the other of R 4 or R 5 is H,
or a pharmaceutically acceptable salt thereof.
2. A method of inducing apoptosis in human breast cancer cells comprising contacting the cancer cell with the compound of claim 1 .
3. A method of treating human breast cancer in a subject in need of said treatment, comprising administering to the subject the compound of claim 1 .
4. The method of claim 3 wherein said method further comprises administering calcium glucarate to the subject.
5. The compound of claim 1 , wherein the salt is a hydrochloride salt or a pyridine salt.
6. A pharmaceutical composition comprising:
compound according to the structure
wherein R 4 or R 5 is NO 2 and the other of R 4 or R 5 is H,
or a pharmaceutically acceptable salt thereof, and,
a pharmaceutically acceptable carrier.